REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,716,000 | -27.8% | 26,997 | +1.6% | 0.01% | -40.0% |
| Q2 2021 | $3,761,000 | -7.9% | 26,576 | -35.1% | 0.01% | -9.1% |
| Q1 2021 | $4,084,000 | +25.5% | 40,959 | +55.7% | 0.01% | +22.2% |
| Q4 2020 | $3,253,000 | +27.5% | 26,312 | +0.4% | 0.01% | 0.0% |
| Q3 2020 | $2,552,000 | -33.7% | 26,196 | +6.3% | 0.01% | -40.0% |
| Q2 2020 | $3,847,000 | +124.3% | 24,655 | +107.5% | 0.02% | +66.7% |
| Q1 2020 | $1,715,000 | -0.3% | 11,882 | +41.1% | 0.01% | 0.0% |
| Q4 2019 | $1,721,000 | +239.4% | 8,419 | +33.4% | 0.01% | +200.0% |
| Q3 2019 | $507,000 | -36.9% | 6,309 | -26.0% | 0.00% | -40.0% |
| Q2 2019 | $804,000 | +6.9% | 8,529 | -3.1% | 0.01% | 0.0% |
| Q1 2019 | $752,000 | – | 8,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |